Takeda Put Actos Profits Before Patient Safety, Jury Told
Japan's Takeda Pharmaceutical Co. put profits from its diabetes drug Actos ahead of patient safety in failing to adequately disclose the drug's link to bladder cancer, an attorney for a man...To view the full article, register now.
Already a subscriber? Click here to view full article